Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > New N43-101 is on the way

<< Previous

Bullboard Posts

Next >>

Comment by BILLMINERon Oct 14, 2010 11:41pm

262 Views

Post# 17567517

RE: New N43-101 is on the way

Looks like they doubled the resource at the Lost deposit. Should come in around 4 million tonnes. Can anyone crunch some numbers with the following. 80 million lbs of copper. 160 million lbs of zinc. 40,000 oz of gold. 1.3 million oz of silver. Valuation of HLO on the lost deposit alone, taking into consideration Hudbay' slice? Very positive indeed.

<< Previous

Bullboard Posts

Next >>

Canopy Growth nears adjusted EBITDA profitability in Q2 2025